Combination therapy salmeterol/fluticasone versus doubling dose of fluticasone in children with asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 182, Issue 10, 2010, Pages 1221-1227

  Vaessen Verberne, Anna A P H ^a   Van Den Berg, Norbert J ^b   Van Nierop, Jan C ^c   Brackel, Hein J L ^d   Gerrits, Gerardus P J M ^e   Hop, Wim C J ^f   Duiverman, Eric J ^g  

^a AMPHIA HOSPITAL   (Netherlands)

^b Flevo Hospital   (Netherlands)

^c EMMA CHILDREN S HOSPITAL   (Netherlands)

^d CATHARINA HOSPITAL   (Netherlands)

^e CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Asthma; Child; Inhaled corticosteroid; Long acting 2 agonist

Indexed keywords

FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; PLACEBO; STEROID;

ADOLESCENT; ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; COMMON COLD; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MAXIMAL EXPIRATORY FLOW; MONOTHERAPY; MULTICENTER STUDY; OROPHARYNX CANDIDIASIS; PEAK EXPIRATORY FLOW; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

ADMINISTRATION, INHALATION; ADOLESCENT; ALBUTEROL; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; RESPIRATORY FUNCTION TESTS;

EID: 78349288447     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201002-0193OC     Document Type: Article

References (31)

1. Expert Panel Report 3: Guidelines for the diagnosis and management of asthma: summary report 2007. J Allergy Clin Immunol 2007;120 (Suppl. 5):S94-138.
2. Global Strategy for Asthma Management and Prevention (revised 2008): Global Initiative for asthma (GINA). 2008. Available from: www.ginasthma.com.
3. Rottier BL. Medicamenteuze onderhoudsbehandeling. Tijdschr Kindergeneeskd 2009;77:243-249.
4. Rachelefsky G. Inhaled corticosteroids and asthma control in children: assessing impairment and risk. Pediatrics 2009;123:353-366.
5. van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Pocock SJ, Kerrebijn KF. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. Am Rev Respir Dis 1992;146:547-554.
6. Koh MS, Tee A, Lasserson TJ, Irving LB. Inhaled corticosteroids compared to placebo for prevention of exercise induced bronchoconstriction. Cochrane Database Syst Rev 2007;3:CD002739.
7. Prenner BM. Role of long-acting beta2-adrenergic agonists in asthma management based on updated asthma guidelines. Curr Opin Pulm Med 2008;14:57-63.
8. British Guidelines on the management of asthma. 2009 (accessed January 2010). Available from: www.brit-thoracic.org.uk
9. Ni CM, Lasserson TJ, Greenstone I, Ducharme FM. Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children. Cochrane Database Syst Rev 2009;3:CD007949.
10. Peters SP. Safety of inhaled corticosteroids in the treatment of persistent asthma. J Natl Med Assoc 2006;98:851-861. (Pubitemid 43846242)
11. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:5-40.
12. Zapletal A. Lung function in children and adolescents: methods, reference values. In: Zapletal A, Samanak M, Paul T, editors. Progress in respiration research. Basel: Karger; 1987. pp. 114-218.
13. Birnie D, thoe Schwartzenberg GW, Hop WC, van Essen-Zandvliet EE, Kerrebijn KF. Does the outcome of the tidal breathing and dosimeter methods of assessing bronchial responsiveness in children with asthma depend on age? Thorax 1990;45:199-202.
14. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med 2005;171:912-930.
15. Nuijsink M, Hop WC, Sterk PJ, Duiverman EJ, de Jongste JC. Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial. Eur Respir J 2007;30:457-466.
16. Masoli M, Weatherall M, Holt S, Beasley R. Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. Thorax 2005;60:730-734.
17. van Noord JA, Schreurs AJ, Mol SJ, Mulder PG. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma. Thorax 1999;54:207-212.
18. Greenstone IR, Ni Chroinin MN, Masse V, Danish A, Magdalinos H, Zhang X, Ducharme FM. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma. Cochrane Database Syst Rev 2005;4:CD005535.
19. Langton HS, Hobbs J, French D, Lenney W. Pilgrim's progress: the effect of salmeterol in older children with chronic severe asthma. Respir Med 1995;89:435-440.
20. Russell G, Williams DA, Weller P, Price JF. Salmeterol xinafoate in children on high dose inhaled steroids. Ann Allergy Asthma Immunol 1995;75:423-428.
21. Morice AH, Peterson S, Beckman O, Kukova Z. Efficacy and safety of a new pressurised metered-dose inhaler formulation of budesonide/formoterol in children with asthma: a superiority and therapeutic equivalence study. Pulm Pharmacol Ther 2008;21:152-159.
22. Pohunek P, Kuna P, Jorup C, De BK. Budesonide/formoterol improves lung function compared with budesonide alone in children with asthma. Pediatr Allergy Immunol 2006;17:458-465.
23. Bisgaard H. Effect of long-acting beta2 agonists on exacerbation rates of asthma in children. Pediatr Pulmonol 2003;36:391-398.
24. Verberne AA, Frost C, Duiverman EJ, Grol MH, Kerrebijn KF. Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group. Am J Respir Crit Care Med 1998;158:213-219.
25. Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med 1998;157:S1-S53. (Pubitemid 28125600)
26. de Blic J, Ogorodova L, Klink R, Sidorenko I, Valiulis A, Hofman J, Bennedbaek O, Anderton S, Attali V, Desfougeres J-L, et al. Salmeterol/ fluticasone propionate vs. double dose fluticasone propionate on lung function and asthma control in children. Pediatr Allergy Immunol 2009;2009:20.
27. Gappa M, Zachgo W, von BA, Kamin W, Stern-Strater C, Steinkamp G. Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED). Pediatr Pulmonol 2009;44:1132-1142.
28. Kamps AW, Roorda RJ, Brand PL. Peak flow diaries in childhood asthma are unreliable. Thorax 2001;56:180-182. (Pubitemid 32260659)
29. Sorkness CA, Lemanske RF Jr, Mauger DT, Boehmer SJ, Chinchilli VM, Martinez FD, Strunk RC, Szefler SJ, Zeiger RS, Bacharier LB, et al. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. J Allergy Clin Immunol 2007;119:64-72.
30. Nelson HS, Chapman KR, Pyke SD, Johnson M, Pritchard JN. Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers. J Allergy Clin Immunol 2003;112:29-36.
31. Lemanske RF Jr, Mauger DT, Sorkness CA, Jackson DJ, Boehmer SJ, Martinez FD, Strunk RC, Szefler SJ, Zeiger RS, Bacharier LB, et al. Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med 2010;362:975-985.